Gyre Therapeutics (GYRE) Net Equity Issued and Repurchased (2009 - 2026)
Gyre Therapeutics' Net Equity Issued and Repurchased was $200,000 in Q2 2026, down 99.1% from $22.04 million a year earlier but up 852.4% from the prior quarter.
Powered by 
Analysis
Gyre Therapeutics (GYRE) Net Equity Issued and Repurchased (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Gyre Therapeutics' Net Equity Issued and Repurchased was -$20.38 million through Jun 30, 2026; for FY2025, it was $2.4 million, up 26.3% from FY2024.
- In earlier years, Net Equity Issued and Repurchased was $1.9 million in FY2024 (-24.0%) and $2.5 million in FY2023.
- Quarterly Net Equity Issued and Repurchased has moved between -$20.96 million (Q3 2025) and $22.04 million (Q2 2025) over five years.
- Compared with a year earlier, Net Equity Issued and Repurchased has declined for three straight quarters, with an average decline of 47.6% over the last four quarters.
- Per Business Quant data, GYRE's Net Equity Issued and Repurchased in the three quarters before Q2 2026 was $21,000 (Q1 2026), $362,000 (Q4 2025) and -$20.96 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -377.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -5.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | -406.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -283.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Gyre Therapeutics | 487.81 Mn | 295.13 Mn | 30.99 Mn | 221,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 221,000.00 |
| Jun 30, 2026 | 200,000.00 |
| Mar 31, 2026 | 21,000.00 |
| Dec 31, 2025 | -22.64 Mn |
| Sep 30, 2025 | 50,000.00 |
| Jun 30, 2025 | 23.52 Mn |
| Mar 31, 2025 | 1.47 Mn |
| Dec 31, 2024 | 593,000.00 |
| Sep 30, 2024 | 374,000.00 |
| Jun 30, 2024 | 275,000.00 |
| Mar 31, 2024 | 658,000.00 |
| Dec 31, 2023 | 2.48 Mn |
| Sep 30, 2023 | 22,000.00 |
| Mar 31, 2023 | 2,000.00 |
| Sep 30, 2022 | 4,000.00 |
| Mar 31, 2022 | 16,000.00 |
| Sep 30, 2021 | 98,000.00 |
| Jun 30, 2021 | -49.10 Mn |
| Mar 31, 2021 | 182,000.00 |
| Sep 30, 2020 | 96,000.00 |
API Access
Gyre Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=GYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "GYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=GYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();